HEALWELL AI

Healwell AI reported adjusted EPS of -$0.02 in Q2-2026 (forecast -$0.0243) on revenue of $32.96 million, just under the consensus of $33.20 million. The stock fell 2.86% after the release to $0.68. In the first half, revenue from continuing operations rose 60% to CAD 66.2 million, adjusted EBITDA improved to CAD 1.9 million, and operating cash flow was positive at CAD 4.5 million. Management is targeting an adjusted EBITDA margin of around 10% by the end of 2026 but expects growth in the AI and Data Science segment at the lower end of the previously stated 30–50% range. » More on de.investing.com

Healwell AI reported a 645% revenue increase in Q2 2025 to $40.5 million and posted a positive EBITDA of $1.9 million for the first time, driven by the health software segment. The company completed the acquisition of Pentavir and integrated Orion Health’s platform; the stock rose 13.57% after the figures, and management announced plans for further growth and continued M&A evaluations. » More on de.investing.com